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REV I EWROBOT ICS AND NEUROPROSTHET I CSPersonalized Neuroprosthetics
David Borton,1 Silvestro Micera,2,3 José del R. Millán,2 Grégoire Courtine1*Decades of technological developments have populated the field of neuroprosthetics with myriad replacement
strategies, neuromodulation therapies, and rehabilitation procedures to improve the quality of life for individuals
with neuromotor disorders. Despite the few but impressive clinical successes, and multiple breakthroughs in animal
models, neuroprosthetic technologies remain mainly confined to sophisticated laboratory environments. We
summarize the core principles and latest achievements in neuroprosthetics, but also address the challenges
that lie along the path toward clinical fruition. We propose a pragmatic framework to personalize neurotechnol-
ogies and rehabilitation for patient-specific impairments to achieve the timely dissemination of neuroprosthetic
medicine.HELP THE BRAIN HELP ITSELF
In the healthy neuromotor system, the development of intention and
motor execution is a dynamic and highly distributed process that origi-
nates in the brain. The intended action is transmitted along the axonal
“super highway” of the spinal cord to “smart circuits” that transform the
descending command into coordinated patterns of muscle activation.
A continuous stream of sensory and motor information is actively
coalesced to ensure the accurate and sequenced execution of move-
ment. The output of the motor cortex and brainstem motor regions
is under the continuous influence of other structures of the brain, in-
cluding the cerebellum and basal ganglia, which are essential for
producing smoothmovements. These contextual information streams
form loops interacting with one another at key integration centers of
the nervous system, such as the association cortices and the thalamus.
Failures of function in one seemingly insignificant processing loop
can, and often do, lead tomarked consequences that induce transient
or permanent deficits in cognitive ability andmotor control. In Parkinson’s
disease (PD), the premature loss of dopaminergic transmission in the
substantia nigra disturbs the basal ganglia loops and motor output
circuitry of the brain, causing tremor, gait disturbance, rigidity, and def-
icits in cognitive function. Demyelination—the phenotype of multiple
sclerosis (MS)—reduces the conductivity of axons, which alters their
ability to convey information to distant circuits. Stroke, although focal
in nature, induces complex and far-reaching effects on the central ner-
vous system (CNS). Less subtle, but particularly palpable, is the marked
consequence resulting from severe spinal cord injury (SCI), which, in
extreme cases, canmake a person completely unable to control the world
around them.
Nervous system disorders have long-term health, economic, and
social consequences. Despite the best available medical treatments,
millions of individuals endure a long life with sensorimotor and cog-
nitive deficits that markedly affect their quality of life. Transplantation
of specific neuronal populations engineered by stem cell technologies
has shown therapeutic efficacy in animal models of neurological dis-
orders (1, 2). Likewise, virus vectors enable manipulating the genetic
constitution of neurons and other neural cells, holding promises to treat
various CNS disorders (3). Nevertheless, the safe and efficacious trans-
lation of these approaches into curative treatments or interventions1Center for Neuroprosthetics and Brain Mind Institute, École Polytechnique Fédérale de
Lausanne, 1015 Lausanne, Switzerland. 2Center for Neuroprosthetics and Institute of
Bioengineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.
3The BioRobotics Institute, Scuola Superiore Sant’Anna, 56026 Pisa, Italy.
*Corresponding author. E-mail: gregoire.courtine@epfl.ch
www.Scienccapable of repairing the injured human CNS remains challenging. Ad-
vances in fundamental brain science, neuroengineering, computational
neuroscience, neurosurgery, neuropharmacology, and robotics have
opened avenues for alternative, neurotechnology-intensive solutions to
cellular and molecular therapies. This broad field of research—termed
neuroprosthetics—taps into spared brain and spinal circuits to replace
or restore sensorimotor functions.
Neuroprosthetic treatments are broadly divided into two categories.
Replacement strategies leverage a sensing neural interface to extract
dynamic information from cortical activity to generate effector control
commands. Pioneering brain-machine interfaces (BMIs) [see related
Perspective by Thakor, this issue (4)] for replacement of function have
allowed nonhuman primates (NHPs) (5–9) and severely paralyzed
persons (10–13) to operate sophisticated actuators, including robotic
arms, to perform activities of daily living by using brain activity only.
Restoration treatments exploit neuromodulation paradigms to regu-
late dysfunctional neuronal circuits with continuous electrical stimulation,
neuropharmacology, or a combination of the two (14–17). Neuro-
modulation of the basal ganglia, spinal cord, retina, and auditory nerves
is improving the lives of countless individualswith PD [deep brain stim-
ulation (DBS)], chronic pain (spinal cord stimulation and intrathecal drug
delivery), blindness (retinal prostheses) [see related Perspective byZrenner,
this issue (18)], or hearing disorders (cochlear implants), respectively.
The marriage of replacement and restoration neuroprosthetic strat-
egies is occurring at a fast pace. An increasing number of brain-to-body
interfaces are establishing electronic bridges to enable the direct neuro-
modulation of denervated spinal segments (19) and muscles (8) from
cortical signals in animalmodels.Meanwhile, the efficacy and spectrum
of neuromodulation treatments are quickly expanding with the design
of closed-loop control systems that aim to adjust therapies based on
individual circuitopathies and detected sensorimotor impairments
(20, 21). These advances in neuroprosthetics represent variations on
the same theme: the need to capitalize on the intrinsic capacity of re-
maining neural circuits and their plasticity to restore function. In this
Review, we describe the core principles and bourgeoning neurotechnol-
ogy underlying the latest and contemplated achievements of neuro-
prosthetic treatments to replace, restore, and rehabilitate sensorimotor
functions. Throughout the review, we also seek to share our vision on
prospective innovations and current impediments to personalizing
neuroprosthetic treatments for distinct neurological disorders to increase
clinical efficacy and relevance. We have chosen limited but concrete
examples to illustrate individualization in clinical settings. In closing,
we address the challenges toward clinical fruition, but also provide aeTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 1
C
R
E
D
IT
:
V.
A
LT
O
U
N
IA
N
/S
C
IE
N
C
E
TR
A
N
SL
A
TI
O
N
A
L
M
E
D
IC
IN
E
REV I EWglimpse at the extraordinary potential of neuroprosthetics to improve
the quality of life for people with neurological disorders. Our objective
is to outline a practical framework for the design of personalized neu-
roprosthetic treatments “to help the brain help itself.”REPLACEMENT: A LITTLE “BIT” GOES A LONG WAY
Replacement strategies leverage interfaces with the brain, spinal cord,
peripheral nerves, and muscles to “listen” to endogenous neuronal ac-
tivity and then extract useful bits of information to control prosthetics.
Controlled effectors range from computers to robotic limbs. Although
there are many accepted and continuously growing terminologies, this
approach primarily falls under the appellation BMIs. Neuroprosthetic
technologies used today rely on an imperfect understanding of local-
ized neuronal circuitry. Yet, these bits of information have enabled the
design of potentially life-changing BMI systems.
Listening to the brain
Information in the cerebral cortex can be garnered from the unit ac-
tion potential or spike and from field potentials (FPs) (Fig. 1A). The FP
recorded by scalp electrodes is called the electroencephalogram (EEG).
FPs recorded inside the skull, epidural or subdural, are called electro-
corticograms (ECoGs), whereas intraparenchymal recordings of FP
are termed local field potentials (LFPs). The early 20th century brought
the first visualizations of brain activity through EEG, but only in 1969
did it become possible to directly interface a sensing electrode with awww.Sciencsingle neuron to achieve operant conditioning of cortical unit activity in
NHPs and later in humans. In 1992, the field transitioned from single-
neuron recording to neural population recording or multiple single units
(MSUs). This breakthrough was made possible by the emergence of the
microelectronic industry, including the silicon-based microelectrode
brain array (MEA) (Fig. 1A).
The proliferation of high-density neural recordings allowed the
discovery of core principles through which cortical networks can co-
ordinate movement. For example, the identification of neural tuning
relationships to upper limb dynamics led to BMI designs based on the
mechanistic understanding of brain transfer functions and movement
decoding (9). During the last two decades, an explosion of neural de-
coding achievements across spatial and temporal scales has enabled
varying degrees of prosthetic control inNHPs.Multidimensionalmotor
information pertaining to intention and execution has been extracted
from neuronal ensemble modulation in the primary motor cortex
(6, 7, 22), premotor cortex (5, 23), and parietal areas (24). This decoding
has enabled NHPs and humans to manipulate neuroprosthetic ac-
tions, ranging from continuous trajectories (5, 6, 11, 12, 25) to discrete
states, such as directions (26), targets (24, 27, 28), and grasp aperture
(8, 10, 22). NHPs have even been able to learn concurrent transforma-
tion functions, which highlighted the development of learning engrams,
termedprostheticmemory (29). Themore pertinent choice of recording
instrumentation for neuroprosthetic designs or neurorehabilitation
depends on the objective of the intervention. AlthoughEEG signalsmay
provide useful intent-related inputs (13), the single-neuron resolution of
intracortical electrodes extracts themaximal amount of information (4).1
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Fig. 1. Neuroprosthetic toolbox. Neurotechnologies are divided into two
categories: sensing and stimulation interfaces. (A to C) Sensing devices are
can recruit neurons in the brain (D), spinal cord (E), and periphery with various
activation volumes and specificities (F). LIFE (longitudinal intrafascicular nervebroken down into subcategories of various resolutions that are interfaced with
thebrain (A), peripheral nerves (B),muscles (C), andbody kinematics (C). (D to F)
Stimulation probes are divided into electrical, optical, and chemical classes thatelectrode) excites a small area of the nerve cross section; TIME (transversal intra-
fascicular multichannel electrode) excites small populations of nerve fibers of
different fascicles over the nerve cross section.eTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 2
REV I EWECoG systems play an intermediate role, providing potentially more
stable signals because of spatial smoothing, yet maintaining a finer res-
olution than EEG recordings (30, 31) (Fig. 1A).
Frontier achievements in BMI
Recently, two groups implanted percutaneous, chronic MEAs into the
cortex of individuals with chronic paralysis (11, 12). Both groups lever-
aged a population of neurons in a small patch of cortex to interpret
the individual’s intended motor action. This BMI enabled voluntary
control of a robotic arm to perform seven-dimensional reach and grasp
movements with remarkable fluidity and even safely bring a cup of
coffee (11) or chocolate (12) from table to mouth—overcoming the tech-
nical and logistical challenges to bring a robotic system into the per-
sonal space. Current BMI developments seek to directly interface brain
signals with other body parts. For example, brain-controlled stimula-
tion of muscles restored grasping in NHPs with transient arm paralysis
(7, 8). Preliminary results using a highly sophisticated musculoskeletal
model in a tetraplegic patient suggest that contemplated BMI-driven
stimulation of muscles, nerves, or spinal cord may restore more natu-
ralistic movements of prosthetic arms (32). This kind of sophisticated
brain-to-body interfaces will critically rely on bio-inspired control
structures (12), including low- and high-level neural information
harvested from multiple brain regions. To this end, the Human Brain
Project (http://www.humanbrainproject.eu/) and the BRAIN Initiative
from the National Institutes of Health (http://www.nih.gov/science/brain/)
may well expand the BMI landscape. Such funding opportunities aim
to enable development of the technological and computational frame-
works necessary to monitor neuronal ensemble modulation from
multiple brain areas. These initiatives coupled with neurotechnolog-
ical advances should help achieve superior, personalized prosthetic
control.
Dynamic cortical activity
Translation of BMI breakthroughs into personalized devices usable in
daily life will face the challenge ofmaintaining stability despite changing
sources of control. Traditional understanding of neural tuning has
proven more complex and variable than originally imagined. Studies
have shown that motor cortex activity co-varies with a broad range of
parameters ofmotor performance—from target location to jointmotion,
torque, and muscle activation patterns (33). Further, a stable representa-
tion in one frame of reference can change across behaviors, postures, and
movements (34), highlighting the capacity of the cortex to hold dy-
namic information required for movement preparation and execution.
This inherent information uncertainty and daily recording instability
often demand recalibration of BMI control algorithms on a daily basis,
which may not be conducive to a normal life-style.
Although procedures have been developed to seek long-term stabil-
ity (35), suchmotor control complexity requires contextual and individ-
ualized adjustments to decoding solutions. New statistical frameworks
have been proposed to explore the high-dimensionality of neural activ-
ity across environments and context, but only recently has implantable
wireless neurotechnology been developed to enable collection of neural
data for such analysis (36, 37). At first sight, versatile encoding may ap-
pear inefficient and metabolically expensive. However, this flexibility
may be critical to adjust motor behaviors to novel contexts while con-
currently facilitating learning and generalization within shared neuro-
nal networks. BMI researchers are seeking to harness context dependency
and versatility of brain activity to their advantage using closed-loopwww.Sciencdecoder adaptation (CLDA) and machine learning. These develop-
ments are paving the way toward personalized BMI technologies.
Listening outside the brain
Few attempts have beenmade to chronically record from spinal circuits
for prosthetic control. Spinal axonal and neuronal packing is extremely
dense and heterogeneous. The uniform parallel distributionmakes unit
isolation difficult for chronic electrophysiology instrumentation. In-
stead, researchers have focused on extracting position and velocity
information from muscle activity (38), peripheral nerve signals (39),
and dorsal root ganglion (DRG) (40, 41) (Fig. 1, A to C). The decoded
information is integrated into closed-loop control systems where they
serve as a motor command or as sensory feedback. For example, real-
time decoding of sensory information fromDRGhas recently been used
to control walking induced by functional electrical stimulation (FES)
(42) or penetrating spinal electrodes (41) in anesthetized cats. Theoret-
ically, these various sources of feedback signals could provide useful bits
of information for controlling a neural prosthesis.
Writing into the brain
Replacement strategies have traditionally focused on reading out from
the brain to control devices but, more recently, have sought to addi-
tionally write perceptions into the brain for replacement of sensation
(43–45). Sensory feedback is necessary to achieve coordinated pros-
thetic control. Visual feedback is generally used to provide information
on executed prosthetic action, but the addition of congruent kinesthetic
information improves performance (46). These results suggest that in-
tegration of multifaceted sensory inputs will play an important role in
augmenting neuroprosthetic control (Fig. 1, D to F) (33). Sensory sub-
stitution, including tactile feedback to body areas where patients retain
somatosensory perception, is an immediate alternative to improve BMI
performance (47). Direct intracorticalmicrostimulationmay be suitable
to provide rich sensory feedback in real time (Fig. 1D) (4, 48). However,
constructive sensory percepts have been difficult to evoke owing to the
uncertain neural activation fields from electrical simulation, the poor
ability of animal models to report directly on quality of sensation, and
the subjective nature of sensory input. NHPs have been able to explore a
simulated environment with an avatar hand and to discriminate virtual
objects on the basis of artificial feedback delivered through intracortical
microstimulation of the primary somatosensory cortex (43). However,
the provided feedback was binary, rather than graded and continuous.
The optogenetic toolbox is providing a range of strategies tomanipulate
the activity of specific microcircuits (49), even of single neurons, while
avoiding electrical stimulation artifacts that impede bidirectional BMI
design. Various strategies are being explored to induce artificial sensory
feedback with optogenetic stimulation (Fig. 1D). Despite the luring
potential for translational medicine (50), the technical and regulatory
hurdles that lie ahead along the path toward turning optogenetic neu-
romodulation therapies into a clinical reality are nontrivial (51).
Plugging into the peripheral nervous system
Multiple approaches have enabled restoration of sensation and active
control of upper limbprosthesis inhumanamputees. Targeted reinnerva-
tion allowed redirection of cutaneous sensation from the amputated
hand to the chest skin (52). Noninvasive stimulation of the reinnervated
chest region with a dense electrode array provided tactile sensation
with precise somatotopic organization. Likewise, intraneural peripheral
electrodes have enabled some degree of specificity in the recruitment ofeTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 3
REV I EWperipheral nerve afferents (Fig. 1F) (53, 54). This technology has also
been used to design neural interfaces in which grip information was de-
coded from electrical activity of forearm muscles [electromyography
(EMG)] (Fig. 1B) (53) or motor nerves (Fig. 1F) (39). Bidirectional
peripheral interfaces have a high potential to translate into useful system
to restore neural control of a prosthetic hand while delivering rich sen-
sory feedback in real time.RESTORATION: A CONVERSATION WITH THE
NERVOUS SYSTEM
Thousands of years ago, humans used electric eels to treat pain—one of
the first documented uses of electricity to deliver therapy. Since then,
advances in material science and charge storage and delivery have
enabled more precise perturbations of the nervous system, including
electrical, optical, and magnetic stimulation (Fig. 1D). In parallel, pro-
gress in neuropharmacology has yielded a wide range of chemical
agents to alter the state of neuronal networks (Fig. 1D). This combined
electrical and pharmacological toolbox has led to newmedical practices
to alleviate many symptoms resulting from neurological disorders. The
challenge for the next generation of neuroprosthetic treatments is to
initiate a productive conversation with the nervous system wherein de-
vices not only deliver therapy but also continuously titrate themselves
on the basis of neural states and detected motor impairments. These
contemplated strategies are referred to as closed-loop neuroprosthetic
system.
Electrically engaging effectors
FES ofmuscles provides safe and easy access tomuscle effectors.Muscle
FES remains one of the few clinically proven and effective prosthetic
therapies that enable basic grasping, standing, bladder control, and
movement rehabilitation (55). A safe andnonsurgical approach consists
of delivering current through surface electrodes placed on the skin over
themuscle to be stimulated (Fig. 1F). These electrodes aremost effective
for activating large and superficial muscles. However, muscle fibers are
recruited in a nonphysiological order, which leads to rapid fatigue.
Owing to skin’s high resistance, FES can require high currents to actuate
muscles, which is often uncomfortable for patients. Implanted FES elec-
trodes avoidmany of surface electrode limitations, but at the expense of
complex surgical procedures. Nevertheless, even greater specificity has
been achieved with peripheral nerve interfaces (Fig. 1F) (38). In partic-
ular, intrafascicular electrodes enabled access to intrinsic hand muscles
that cannot be recruited independently using conventional FES (56).
Complex reach-to-grasp movements have also been evoked in NHPs
when delivering intraspinal microstimulation at specific locations of
cervical segments (Fig. 1E) (57). However, there is no sufficiently de-
tailed atlas to guide the placement ofmicrowires to evoke distinctmove-
ment, which severely limits neuroprosthetic applications (57). Practical
FES systems will have to solve the equation between variable muscle re-
cruitment specificity, surgical complexity, and cost to personalize so-
lutions that mediate meaningful benefits.
Reanimating the “spinal brain”
The spinal sensorimotor infrastructure has traditionally been viewed as
an assembly of reflex subsystems and central pattern generators (CPGs)
that produce automated and stereotypical motor activity in response to
sensory input or descending command (58). The high degree of auto-www.Sciencmaticity embedded in spinal circuits enables the execution of complex
motor behaviors with considerable precision and without conscious
thought (59). The spinal brain acts as a smart information-processing
interface that integrates dynamic input from sensory ensemble and
makes a decision on how to stably and continuously adjust motor out-
put to meet environmental constraints (59). Despite these advanced
properties, the markedly depressed state of the spinal cord after in-
jury prevents the production of standing and walking. Consequently,
much effort has been invested in developing paradigms to replace the
missing sources of neuromodulation and excitation that are normal-
ly delivered to spinal sensorimotor circuits for coordinatingmovement.
Electrical stimulation has been the primary strategy used to compensate
for the interrupted source of spinal excitation after injury. Continuous
electrical stimulations applied to the dorsal roots (60), over the dorsal
aspect of the spinal cord (16), or directly into the ventral horn of lumbar
segments (41) (Fig. 1E), have shown the ability to elicit standing and
stepping patterns in animal models and humans with SCI (16, 59),
PD (15), and MS (61). In combination with monoamine agonists (62),
epidural electrical stimulation of lumbosacral circuits has been able to
restore full weight-bearing locomotion in rats with complete SCI (17).
This electrochemical neuroprosthesis replaces the missing source of
neuromodulation and excitation after the interruption of descending
pathways, although the exact mechanisms remain unclear.
Neurotechnology and stimulation protocols are at the early stages
of development. Empirical knowledge and visual observations have
guided electrode positioning, as well as the selection of electrode con-
figurations and stimulation parameters. Extensive mappings revealed
that various locations and stimulation profiles are necessary to facilitate
standing, stepping, and isolated movements (16, 59). This manual
tuning is impractical and suboptimal. These experiments emphasize
the need to establish a mechanistic framework to personalize multisite
stimulation algorithms and develop closed-loop control systems that
take full advantage of this paradigm to facilitate movement in motor-
impaired subjects.
Regulating brain function
Regulation of dysfunctional neuronal circuits with neuromodulation
therapies has broadened the spectrum of treatment options for neuro-
logical disorders (14). For example, dopamine precursors (pharmaco-
logical modulation) and DBS (electrical modulation; Fig. 1D) of the
basal ganglia circuitry have become commonly applied therapies
to mitigate, independently and synergistically, many of the cognitive
andmotor symptoms associated with PD. The introduction of electrical
currents into deep brain structures recruits a multiplicity of axonal,
somatic, and dendritic elements—each with different functions, latencies,
and propagative properties. The recruitment of neural structures de-
pends on stimulationmodality, charge densities, local synaptic arrange-
ments, and stimulation profile. This plurality of mechanisms has led to
elusive and contradictory hypotheses to explain the therapeutic impact
ofDBS (14). A catalog has been proposedwherein each of the individual
elements in the constellation of symptoms maps onto specific neural
subcircuits—termed symptomatotopy (14). Unfortunately, the ability
to draw such a map is questionable—especially for human-specific dis-
ease phenotypes for which experimental data are lacking. According to
ClinicalTrials.gov, there are nearly 100 ongoing clinical trials that are
exploring the impact of DBS for reducing detrimental effects of many
neurological disorders, including major depression disorder, obsessive-
compulsive disorder, chronic pain, and dystonia. However, incompleteeTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 4
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nature of DBS are hindering the translation of these approaches (14).
Today, electrodes for brain stimulation and recording take very few
physical forms (63) and fail to leverage our understanding of neuro-
motor disorders to optimize efficacy. Novel electrode design and ad-
vanced current steering methods aim to increase the specificity and
directionality of DBS to expand therapeutic flexibility. Nevertheless,
the inherent limitations of electrical stimulation may prevent achieving
personalization of DBS treatments.
Shedding light on brain circuits
The burgeoning field of optogenetics lends perspective on the mecha-
nisms of therapeutic interventions, potentially leading to fundamentally
new neuromodulation paradigms. The integration of optogenetic
technologies into neuromodulation treat-
ments is already bearing fruit, bringing
newprosthetic tools, targets, and therapeu-
tic interventions for neuromotor diseases
(21, 49, 50, 64). Refined delivery of light,
cell-specific targeting methods and ge-
netic control of expression enable well-
controlled neural excitation or inhibition
of brain, spinal cord, and peripheral nerves
(49, 50). However, clinical use of optoge-
netic technology relies on an enhanced
understanding of how damaged neuronal
circuits and their interconnections produce
disease (circuitopathies), the identification
of specific promoters to drive expression
of light-sensitive channels, the safe de-
livery of optical stimulation, and, cru-
cially, the safe and efficacious translation
of gene therapy to humans.Moreover, the
first attempt to implement the optogenetic
toolbox in NHPs has revealed unexpected
obstacles. Although optogenetic constructs
robustly modulate neural activity in NHPs
(65), optically induced behavioral effects
have been only obtained in a few animal
studies, under restricted conditions, and
with limited scope (66, 67). Despite the
luring potential for transforming restor-
ative medicine, and initiatives for commer-
cial exploration (http://circuittx.com/),
excitementmust be tempered by objective
reality. Numerous practical, technical, and
regulatory hurdles lie in translating opto-
genetic neuromodulation therapies to
common clinical practice (51).
Bringing the brain into the loop
Automated closed-loop control systems
yield great potential to improve neuro-
modulation therapies by reducing titration
latency and adjusting parameters to meet
dynamic patient-specific needs (Fig. 2)
(20). Industrial developments of clini-
cally viable neuromodulation platformswww.Sciencprovide tools to personalize stimulation algorithms on the basis of
FP recordings from the brain (36). Epilepsy has been an early target
for closed-loop neuromodulation where systems detect aberrant
activity through ECoG or cortical MEAs and, based on a software-
implemented control policy, deliver electrical (68) or optogenetic (21)
stimulation to disturb aberrant network states. Closed-loop plat-
forms serve as the foundation for further integration of biosignals to
enhance patient-specific data collection. Moreover, the introduction
of varying neuromodulation features offers the opportunity to alter
the dynamic state of neuronal networks, which may aid in under-
standing diseased states of the nervous system. Optimal closed-loop
control systems must incorporate policies between neural circuits and
stimulation algorithms (co-adaptive) to reach maximum therapeutic
effects.Standard
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Fig. 2. Closed-loop neuroprosthetic design. (A to F) Motor intent extracted from the central and
peripheral nervous system (A), informed by composite movement feedback (B), are processed
through co-adaptive algorithms (C). This process builds control policies to deliver stimulation to
the brain (D), spinal cord, peripheral nerves, and muscles (E), and/or to control robotics, smart pros-
thetics, or other assistive technologies (F). This system design includes natural and artificial feedback
loops to the user and control policies. This marriage of BMIs and neuromodulation therapies through
closed-loop control systems is occurring at a fast pace. Grasp reconstructions reproduced from (22)
with permission. Prosthetic arm and leg obtained from Wikipedia Commons.eTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 5
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During most of the 20th century, neuroscientists shared Ramon y
Cajal’s conception of the adult CNS: “in the adult brain, nervous path-
ways are fixed and immutable; everything may die, nothing may be
regenerated” (69). Today, however, structural and functional neuro-
plasticity of spared brain regions and their interconnections form the
basis for functional recovery after insult. Traumatic injuries, cerebral
infarction, and other sudden neural damage open a window of op-
portunity for increased neuroplasticity, which can mediate extensive
restoration of sensorimotor functions after moderate CNS lesion. To
enhance this remodeling, neuroprosthetic systems must maximize
the engagement of neural systems during training and ensure that
the brain works together with the spinal cord.
Activity-dependent neuroplasticity
The field of neurorehabilitation has long understood the implica-
tions of neuroplasticity for the design of activity-based interventions
to increase recovery after neuromotor disorders. In the early 1980s,
disruptive experiments first illustrated the power of activity-dependent
neuroplasticity after injury. Despite the complete interruption of su-
praspinal input, intense daily training enabled the spinal cord of
adult cats to learn to step on amotorized treadmill or to stand quietly
for hours with full weight bearing (70). However, cats that had been
trained to stand stepped very poorly. Inversely, cats that were trained
to walk for hours on a treadmill had limited ability to stand. Task-
specific activation of sensorimotor circuits selected and reinforced
subsets of connections and neurons in a way that substantially im-
proved the ability of the spinal brain to perform the practiced move-
ment successfully (59, 70). Functional and structural rearrangements
through mechanisms of Hebbian neuroplasticity, local axonal
growth, synapse formation, stabilization, and elimination have since
been observed in the brain and spinal cord after various insults (71, 72).
Activity-dependent neuroplasticity at the systems level implies that the
therapeutic effects of training will strongly depend on the following:
(i) the type of practiced motor task, (ii) the availability of meaningful
sensory information to shape the remodeling of neuronal circuits,
and (iii) the presence of robust and coinciding activity throughout
the brain and spinal cord during rehabilitation. These practical find-
ings are steering the design of robotic interfaces and neuroprosthetic
systems to augment the beneficial impact of neurorehabilitation,
which we summarize below.
Robot-assisted training
Robotic engineering pioneered the application of devices to enhance
activity-based neuroplasticity with training after insult (73, 74). Al-
though there are different views on the more suitable strategies for
the design of rehabilitation robots (75), the objective of these interfaces
is to enable adjustable and highly reproducible assistance of lower or
upper limb movements during intensive task-specific training. Ideally,
rehabilitation robots only require supervision from a physiotherapist
who sets the parameters of the mechatronic structure to continuously
challenge the patient’s neuromuscular system. Robotic interfaces also
monitor the patient’s participation and performance, which provides
a quantitative and objective evaluation of training outcome. These com-
bined features have contributed to the popularity and success of reha-
bilitation robotics in the clinical setting, which led to the accelerated
development of increasingly complex, multiple degree-of-freedom
interfaces. However, since the first introduction of robotic devices forwww.Sciencoccupational medicine in the 1990s (73, 74), exoskeletons and other
training interfaces have failed to demonstrate superior capabilities to
restore function compared to conventional therapy. For example,
robot-assisted training delivered in the acute or chronic stage after a
stroke can improve recovery of upper limb function, but performance
has been in the best scenario equivalent to those obtained with manual
guidance (76). Nevertheless, even more controversial is the potential
benefit of exercise driven by a lower limb orthosis, which has repeatedly
been questioned in comparative clinical trials involvingmultiple neuro-
logical disorders [see related Perspective by Goldfarb et al., this issue
(77)]. Despite important proofs of feasibility, robotic engineering has
yet to leverage the disruptive potential of robotic technology to surpass
conventional therapies. This challenge is giving birth to a new field of
research merging neuroprosthetics and soft robotics, which has been
termed “soft” neurorobotics.
Soft neurorobotics is a new class of rehabilitation interfaces that
seeks to provide more natural, interactive, and safer robotic assistance
through soft design. Engineers are integrating “softness” through three
synergistic building blocks. First, they use soft materials, such as silicon
rubber derivatives, to design wearable interfaces that are comfortable
and lightweight, and whose ergonomic design is personalized through
anthropometry. Second, they develop soft hardware, including soft ac-
tuators (78) and stretchable sensors (79), to enable compliant interactions
between the user and the robotic interface. Third, they use soft control
algorithms that integrate multilevel biological and neurological feedback
to personalize the degree of assistance based on the current state of the
limbs, the intended movement, and the physiological condition of the
trained subject.
The first generation of compliant robotic interfaces has achieved
softness through variable impedance control. For example, the use of
series elastic actuators, which consist of an elastic element inserted
between a conventional motor and the subject, allows the robotic in-
terface to be entirely decoupled from the user—the robot becomes
transparent (80). Compliant interactions enable the robot to act as a
postural neuroprosthesis that continuously personalizes the amount
of support and assistance on the basis of the performed task and subject-
specific impairments. This type of robotic postural neuroprosthesis instant-
ly restores unexpected motor control capacities in rats with partial SCI or
stroke (80). Adaptive control algorithms are the main tools used to in-
tegrate softness in current rehabilitation robots. Instead of moving the
limbs along predefined trajectories, robotic assistance is continuously
adjusted to limb state (81), active subject participation (75), brain states
(82), and bio-cooperation markers such as heart rate (83). Current re-
habilitation robots require the user to adapt to the training paradigm
through uncomfortable, rigid master-slave interactions. Although
many obstacles remain, soft neurorobotics promises to personalize the
rehabilitation environment to the anthropometric, physiological, and
psychological features of the user to enhance remodeling of the brain
and spinal cord with customized training.
Multisystem neurorehabilitation
Activity-based therapies are designed with the reasoning that the re-
petitive exposure to task-specific patterns of sensory input will reinforce
the activated sensorimotor circuits to promote functional improvement.
Although this approach is effective in individuals who retain the ability
to engage motor circuits (72), training after more severe lesions that
spare limited or no ability to engage residual function fails to promote
useful neuroplasticity in sensorimotor pathways. What is the rationaleeTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 6
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ical threshold of activity may be necessary for neuronal circuits to re-
spond to task-specific proprioceptive input. Several neuroprosthetic
systems have shown the ability to manipulate neural activity directly
within the brain and spinal cord, or indirectly through peripheral nerve
or muscle stimulation, to promote active movement.
Application of these activity-enabling systems during training,
termedmultisystemneurorehabilitation (17), has led to long-lasting im-
provements of motor functions in animal models and humans with
neuromotor disorders. For example, treadmill-based step training en-
abled by an electrochemical spinal neuroprosthesis mediated marked
amelioration of locomotor capacities in severely paralyzed rats (17, 59).
Repeated practice under the presence of chemical and electrical spinal
stimulations, which enabled a so-called functional state (59), triggered
structural and functional remodeling of sensorimotor circuits, but only
in the engaged spinal cord. Treadmill-restricted training failed to engage
the brain, and no (or limited) activity-dependent neuroplasticity took
place in spared descending pathways; in this condition, the spinal brain
appears to work alone. Robot-assisted training paradigms that are de-
signed to encourage the brain to communicate with the electrochemically
enabled spinal cord instead restored supraspinal control over refined gait
movements in rats with an SCI, leading to permanent paralysis (17).
Recovery of voluntary locomotion relied on the ubiquitous remodeling
of brain and spinal neuronal pathways. Similar results were obtained in
amanwith chronic paraplegiawho pursued stand training enabledwith
electrical spinal cord stimulation (16). After several months, the patient
regained the capacity to consciously control joint-specific movements
of the leg, but only in the electrically enabled state. These experiments in
animal models and humans with SCI illustrate the core principle of
multisystem neurorehabilitation: provide neuroprosthetic systems to
enable and encourage the use of spared, but functionally dormant, neu-
ronal pathways and circuits to boost activity-dependent neuroplasticity
and recovery.
Encouraging the brain to join the party
Activity-enabling systems have also been exploited to rehabilitate upper
limb function, which more heavily relies on supraspinal contribution
compared to gait control (58). Facilitation of arm and handmovements
using FES systems, peripheral nerve stimulation, or intraspinal stimula-
tion has promoted improvements of motor functions in animal models
and in individuals with stroke and cervical SCI (84). However, carry-
over effects of training have been contingent on the presence of vol-
untary activation. These therapeutic strategies share the same conceptual
framework as Hebbian learning: ensure that the exogenous recruitment
of muscles—and evoked afferent feedback—temporally collides with a
residual descending drive to trigger Hebbian-like neuroplasticity in
the activated sensorimotor circuits (19, 57). Consequently, the degree of
neuroplasticity and recovery is likely to correlate with the strength and
timing of the dialogue between spared and active brain and spinal cir-
cuitries. BMI technology offers the opportunity to incorporate brain
signals into closed-loop stimulation algorithms to improve communi-
cation synchrony. For example, NHPs with a lateral hemisection SCI
have learned to increase motor cortex LFP power to volitionally boost
ongoing muscle activity with recurrent intraspinal stimulation to per-
form a force-matching task with their paretic upper limb (85). Likewise,
preliminary evaluations in individuals with chronic stroke suggest that
rehabilitation enabled by BMI-guided electrical stimulation of arm mus-
cles may promote unexpected gains in function (Fig. 2, A and F) (86, 87).www.SciencIn these applications, movement intention was derived from EEG
signals, which contain a limited spectrum of prosthetic actions to train
movement. However, restoration of a simple function may shift the
functional state of the motor infrastructure, establishing the conditions
for generalization of learning and improvement to more complex tasks.
For more skilled movements, MSU or ECoG recordings may pro-
vide sufficient degrees of freedom to engage hand and arm muscles in
the context of rehabilitation training. The BMI toolbox enables moni-
toring motor attention during training to ensure active participation of
the brain, which is essential to trigger activity-dependent neuroplasticity
(17, 82, 88). Although preliminary, these studies are mapping the fu-
ture of multisystem neurorehabilitation—bidirectional BMI technology
to relay decoded intent to networked prosthetic systems (Fig. 2). The
underlying objective is to ensure that the neuroprosthetic technology
and spared neural systems work hand in hand to promote the max-
imum possible degree of neuroplasticity and functional recovery for
each patient.
Unexpected mathematics
Multisystem neurorehabilitation exploits activity-dependent neuro-
plasticity to maximize recovery after injury, but the amount of spared
neural connectivity restricts the therapeutic potential of such inter-
ventions. Plasticity-enhancing neurostimulation methods (72), nerve
growth–promoting interventions (89, 90), and stem cell technology
(91) provide tools to soften this physical boundary and increase neuro-
plasticity with training. These strategies aim to replace damaged neural
elements, which position them at the fringe of neuroprosthetics. Theo-
retically, rehabilitation in a growth-permissive environment is expected
to increase functional recovery. However, the first combinatorial at-
tempts in rat models of SCI have uncovered potentially detrimental
synergies (89) and complex interactions (90) between task-specific ex-
ercise and plasticity-enhancing therapies. The type and quality of the
practiced movements seem to determine the balance between bene-
ficial and detrimental neuroplasticity (89, 90). These preliminary results
stress the importance of integrating robotic and neuroprosthetic
systems to enable coordinated and powerful movement during training
to steer the functional integration of newly formed circuits and regen-
erative axons into the spared neuromotor infrastructure. The combina-
tion of neuroprosthetic training andneuroregenerative strategies, which
recruit distinct mechanisms, promises to be complex, but may be the
key to improve recovery after the most severe forms of neuromotor im-
pairment (Fig. 3).FROM PERSONALIZED NEUROPROSTHETICS TO
CLINICAL REALITY
Decades of technological developments have engendered a plurality
of neuroprosthetic strategies to replace or restore impaired sensori-
motor functions after neurological disorders. Concurrently, advances
in imaging and clinical neurosciences have contributed to improving
our understanding of circuitopathies, emphasizing the importance of
patient-centered approaches in the design of therapies. However, these
advances in neural prosthetics and neurology have yet to translate into
commonmedical practice. The therapeutic toolbox at clinicians’ dis-
posal lacks reliable, safe, versatile, and meaningful neuroprosthetic
options to help people with neuromotor disorders. Neuroprosthetic
interfaces mainly remain confined to the stereotyped environments ofeTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 7
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REV I EWsophisticated laboratories where skilled engineers must operate and
continuously tune the technology. Dissemination of personalized neu-
roprosthetics among the patient population is contingent on several non-
trivial clinical, technical, organizational, and regulatory hurdles—the
resolution ofwhich relies on the concerted efforts ofworld-class engineers,
clinicians, therapists, funding agencies, and regulatory bodies (Fig. 4).
We address some of these challenges.
Neuroprosthetics 2.0
Success in translational neuroprosthetics has been achieved primarily
while working with severely paralyzed individuals. These achievements
have demonstrated that current neurotechnologies are safe andmay im-
prove quality of life. The time has come to broaden the spectrum of tar-
geted neurological impairments, specifically to evaluate the therapeutic
effect of neuroprosthetic treatments in individuals with less-severe def-
icits than severely paralyzed persons, the latter being the typical subjectswww.Sciencfor early clinical investigations (11, 12, 16, 88). For example, implemen-
tation of neuroprosthetic systems may uncover distinct treatment mech-
anisms for individualswithmoderate versus severe SCI, including growth
of new connections through variable volume of spared tissue (17). The
potential risk-benefit ratio of surgical interventions for individuals with
moderate deficits is high. Nevertheless, proof of efficacy in few subjects
would suffice to trigger the deployment of such procedures in larger clin-
ical populations. Inclusion of an educated patient’s perspective in the
decision-making process for treatment design may further accelerate
widespread clinical use (Fig. 4). This step forward requires improved
diagnosis platforms to identify the balance between high-risk, high-gain
interventions and low-risk, but pragmatic and efficient, treatments that
will maximize recovery for each patient (Fig. 4).
Currently, neurologists make these decisions on the basis of their
day-to-day experience and collective wisdom. Data-mining techniques
provide statistical tools to articulate this classification with objective
markers gathered into multicenter database, to create evidence-based
personalization of treatment design (92). For example, the Stanford,
Harvard, andUniversity of California, LosAngeles, hospitals are among
the first to digitize patient records, allowing “Google search” across a
patients’ health history. Structural, functional, and electrophysiological
analyses of brain and spinal neuronal networks are common practice
in clinical centers. Likewise, technology exists to automatically collect
high-resolution information from patients and to standardize functional
assessments across clinical centers (Fig. 4). A few U.S. government–
and EU government–funded initiatives have begun to implement sys-
tematic procedures for harmonizing data quality, standards, and best
practices in brain and spinal injury research [for example, European
Multicenter Study on Human Spinal Cord Injury (EMSCI; http://www.
emsci.org/), the PD genetic association database (http://www.pdgene.
org/), and the Alzheimer’s association (http://www.alz.org/)]. Similar
standardization must be implemented in robotic and neuroprosthetic
system designs. Synergizing “big data,” standardized protocols, and
compatible technologies can serve three essential goals for personal-
ized neuroprosthetics: (i) enable the training of therapists in common
rehabilitative technologies, (ii) map patient-specific circuitopathies
and potential for recovery to distinct combinations of neuroprosthetic
technologies and individualized neurorehabilitation programs, and (iii)
monitor evolution of disease states during training to continuously ad-
just neuroprosthetic systems and rehabilitation procedures to patient-
specific features.
Relevant animal models
Most interventions developed in rodent models of neuromotor dis-
orders have failed to translate into clinical therapies. The importance
of neocortical networks and corticospinal projections for the control
of movement has steadily increased during primate evolution. These
discrepancies in themotor system of rodents versus primates have non-
trivial consequences for disease etiology, mechanisms of recovery, and
therapeutic design (93). For example, cortical stroke leads to minimal
locomotor deficits in rats (80), whereas the same lesions have marked
impact on gait in NHPs and humans (72). Moreover, neuroprosthetics
rely on advanced microsystems that may be implanted temporally, or
for a lifetime. Although preliminary evaluations and iterative adjust-
ments of implanted devices are conveniently conducted in rodents, dif-
ferences in size and immune responses between rodents and humans
(94) preclude a direct translation to clinically usable devices. Conse-
quently, for many applications, there is a critical need for conductingAdaptive robotic support
Wireless neural recording
Patching damaged circuits
Electrochemical therapy
Real-time motion analysis
Fig. 3. Neuroprosthetic treatment integration. A panoply of neuro-
technologies, neurorehabilitationparadigms, andneural repair interventions
has shown efficacy to improve functional recovery after neuromotor dis-
orders in animal models and humans. The next generation of treatments
will integrate these paradigms tomaximize recovery. Here, we specifically
illustrate the putative combination of treatment paradigms for individuals
with SCI.eTranslationalMedicine.org 6 November 2013 Vol 5 Issue 210 210rv2 8
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demonstrate efficacy of therapeutic interventions. Despite the stigma
associated with publicly funded primate research (95), we argue that
there is much to gain with few, but well-designed, NHP studies (96)
to accelerate the translation of promising interventions developed in ro-
dents to viable therapies for humans (93).
Impediments to biologically tolerant devices
Neural engineers have developed sophisticated neural interfaces, but
these devices have yet to reach the critical threshold to operate safely,
chronically, and reliably to mediate long-lasting therapeutic benefits
(4). This translational step is an underestimated challenge (51, 97).
The physical mismatch of materials at the metal-to-scalp or metal-to-
electrolyte interface is a constant source of noise and signal degradation,
which leads to decreased stability of inputs to decoders (98, 99), and
undesirable biological responses, including inflammation, edema, and
higher risk of infection (100, 101). Implanted neurosensing and neuro-
stimulating devices must cope with these inherent error signals while
behaving transparently to the host body (bio-tolerance). Achieving such
transparency requires improved electrodematerials to ensure long-term
performance, in conjunction with embedded electronics that are wire-
less, autonomous, and reliable. For example, difficulties in maintaining
high-fidelity neural recordings over years, along with decoder instability,
continue to be key impediments in the translation of BMI systems to
common medical practice. Neuro-attractive molecules combined withwww.ScienceTranslationalMedicine.org 6improvedprobedesignmayalleviatemany
of the obstacles for long-lasting neural in-
terfaces (101).Current flexible devicepack-
agingprocesses forbiocompatiblepolymeric
insulationoffer erratic dependability against
the aggressive environment of the human
body (102). Hence,most packaging schemes
for chronic therapeutic use have been lim-
ited to solid titanium hermetic packages
or equally rigid ceramics. Carefully de-
signed polymers maximizing flexibility,
bio-tolerance, andminimizing porositymay
overcome many of the current implant-
able device packaging challenges, but
they remain at the early stages of devel-
opment (103).
Concerted efforts have been necessary
to build implantable devices for real-time
wireless transmission of tens ofmegabytes
per second of neurophysiological informa-
tion to external computational centers (37).
However, their translation touse inhumans
remains elusive. Engineers seek to build
optimized data and power transmission
solutions for implantablemedical devices.
These developments have culminated in
commercialized products and clinically
available therapies, including pacemakers,
DBS systems, andcochlear implants.How-
ever, real-time circuitopathy analysis re-
quires spatiotemporally specific broadband
recordings from hundreds, or even thou-
sands, of output channels. The FederalCommunications Commission (FCC) has recently allotted a dedicated
radio spectrum for wearable medical device communication, termed
MBAN (Medical Body Area Network). Nevertheless, the ever-growing
need for high-ratemedical data collectionwill require data transmission
capabilities reaching orders ofmagnitude above the allotted rate. Cellular
communication technology, advanced by both private and public fund-
ing, must be leveraged to meet these unprecedented demands (104).
The personal and institutional cost of doing business
Neuroprosthetic treatments rely on the integration of multiple tech-
nologies into one cohesive therapy. Regulatory pathways through the
FDA (U.S. Food and Drug Administration) (http://www.fda.gov/
CombinationProducts/) or EMA (European Medicines Agency) (http://
www.ema.europa.eu, “hybrid medical product”) for multisystem de-
sign are prohibitively expensive and combinatorially complex. For
example, the clinical implementation of an electrochemical spinal neu-
roprosthesis to restore locomotion after SCI (17) would require ethical
authorizations for the electrode array, implanted pulse generator, real-
time control policies, implanted motion sensors, multicompartment
drug delivery systems, and multicomponent chemical cocktails (Fig. 3).
Although some of these components may be tested and validated indi-
vidually, proof of efficacy may critically rely on their joint implementa-
tion. Nevertheless, can this be attained? Without corporate partners, a
sound business model, and substantial therapeutic evidence in animal
models, potentially useful neuroprosthetic systems remain stranded onStandardization
Regulatory
bodies
Healthcare
provider
Personalized
neuroprosthetics
Diagnosis
Patient
Physician
MRI/fMRI
Brain signal analysis
TMS
DBS
Family
Cost
Individual capacity
Timing
Core neurotechnology platform
Circuitopathy etiology
Informed by relevant
animal models
Sensing and stimulation neural interfaces
Behavioral assessment with
disease neuropathology
Functional assessment
Based on improved symptomatopy
Standardized across care centers
Consortium
decision-making
Neurosurgeons
Neurologists
Physiotherapists
Neuroengineers
Patient
Fig. 4. Roadmap to personalize neuroprosthetics. The path toward personalization necessitates high-
resolution disease diagnosis enabled by new core technology platforms and educated by animal models.
Functional assessment by the physician attempts to bridge gap between behavioral and etiological source
of pathology. An informed consortiumof neuroscientists, neurologists, neuroengineers, neurosurgeons, and
the patient makes decisions. Regulatory bodies and health care providers are the final enablers of neuro-
prosthetic technology. MRI, magnetic resonance imaging; fMRI, functional magnetic resonance imaging;
TMS, transcranial magnetic stimulation.November 2013 Vol 5 Issue 210 210rv2 9
REV I EWthe bench, unlikely to reach the bedside. The BRAIN initiative is a first
step toward funding the conception and implementation of next-
generation neuroprosthetic treatments. However, there is a critical lack
of institutional funding to fill the gap between breakthroughs in animal
models and large-scale clinical trials. Moreover, dissemination to com-
mon medical practice faces the bitter equation of high cost plus un-
certain improvements in quality of life—a balance that may level
differently for patients and health care providers.THE FUTURE OF PERSONALIZED
NEUROPROSTHETIC MEDICINE
Translation of neuroprosthetic technologies to clinical practice is im-
minent. This confidence arises from few, but powerful, neuropros-
thetic treatments that are already improving the life of countless
individuals (cochlear implants, retinal prosthesis, DBS, etc.), as well
as inspiring breakthroughs in animal models and human case studies
(for example, http://www.BrainGate2.org). Neuromotor disorders en-
compass multifaceted etiologies and phenotypes that necessitate indi-
vidualized interventions. The field of neuroprosthetics has populated
clinical centers and research laboratories with an abundance of neu-
rotechnologies for diagnosis and treatments. Through standardization,
existing and contemplated neurotechnologies could be assembled flex-
ibly to personalize neuroprosthetic treatments for each patient and
deficit, both in the clinic and at home. Compared tomedical treatments
based on drug delivery or surgery, neuroprosthetics necessitate the
orchestrated contribution from neurosurgeons, neurologists, physio-
therapists, and neuroengineers to conceive complex treatments centered
on the patient. This transdisciplinary framework is only beginning to
be applied (105). Through well-organized consortia combining syn-
ergistic diagnosis and technological platforms, neuroprosthetics may
soon become a treatment option to improve the quality of life for in-
dividuals with neuromotor disorders. Althoughmany obstacles remain,
personalized neuroprosthetics offer a panoply of technology-intensive
but pragmatic solutions “to help the brain help itself ” thatmay be staring
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